(0.06%) 5 251.78 points
(0.01%) 39 766 points
(-0.11%) 16 382 points
(2.00%) $82.98
(1.51%) $1.744
(1.18%) $2 238.90
(0.73%) $24.93
(1.27%) $921.25
(0.30%) $0.926
(0.75%) $10.85
(0.10%) $0.792
(0.14%) $92.57
@ $19.65
Issued: 14 Feb 2024 @ 15:45
Return: 9.16%
Previous signal: Feb 14 - 09:30
Previous signal:
Return: -2.04 %
Live Chart Being Loaded With Signals
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer...
Stats | |
---|---|
Today's Volume | 187 893 |
Average Volume | 1.48M |
Market Cap | 1.63B |
EPS | $0 ( 2024-02-27 ) |
Next earnings date | ( $-0.560 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -10.31 |
ATR14 | $0.0220 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-29 | Doyle Thomas James | Sell | 594 | Common Stock |
2024-01-29 | Doyle Thomas James | Sell | 761 | Common Stock |
2024-01-29 | Doyle Thomas James | Sell | 963 | Common Stock |
2024-01-29 | Bair Teresa Brophy | Sell | 2 053 | Common Stock |
2024-01-29 | Ford Kathleen | Sell | 1 496 | Common Stock |
INSIDER POWER |
---|
40.80 |
Last 95 transactions |
Buy: 6 371 376 | Sell: 2 723 562 |
Volume Correlation
Kura Oncology Inc Correlation
10 Most Positive Correlations | |
---|---|
RMRM | 0.943 |
GAINL | 0.888 |
LQDT | 0.876 |
TRVN | 0.857 |
SLNH | 0.85 |
QTEK | 0.834 |
SWVL | 0.825 |
HYMC | 0.824 |
VYNT | 0.817 |
LITM | 0.808 |
10 Most Negative Correlations | |
---|---|
FANH | -0.844 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kura Oncology Inc Correlation - Currency/Commodity
Kura Oncology Inc Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-849 000 (0.00 %) |
EPS: | $-2.08 |
Q4 | 2023 |
Revenue: | $1.27M |
Gross Profit: | $1.06M (83.15 %) |
EPS: | $-0.550 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $-216 000 (0.00 %) |
EPS: | $-0.500 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $-213 000 (0.00 %) |
EPS: | $-0.530 |
Financial Reports:
No articles found.
Kura Oncology Inc
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators